PFM Health Sciences, LP — 13F Holdings & Portfolio
CIK 1442756 · latest 13F-HR filed 2026-05-15
PFM Health Sciences, LP manages $1.10B in 13F-reported U.S. long-equity assets across 83 reported positions as of its 2026-03-31 13F-HR filing. Its largest disclosed positions are THC (6.86%), LLY (5.52%), XBI (5.30%). Quarter over quarter (versus its 2025-12-31 filing) the fund opened 19 new positions, exited 19, added to 28, and trimmed 22.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
$1.10B
Long-equity book
83
Distinct positions
2026-03-31
Filed 2026-05-15
+19 / −19 / ↑28 / ↓22
vs 2025-12-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- JAZZ PHARMACEUTICALS PLC$25.1M +292.2%
- MADRIGAL PHARMACEUTICALS INC$13.6M +322.9%
- DIANTHUS THERAPEUTICS INC$10.3M +252.0%
- RHYTHM PHARMACEUTICALS INC$7.6M +176.1%
- CELLDEX THERAPEUTICS INC NEW$6.7M +185.0%
Top Trims
- CENTENE CORP DEL-$21.2M -71.1%
- THERMO FISHER SCIENTIFIC INC-$14.7M -66.8%
- ICON PLC-$14.7M -69.7%
- ELI LILLY & CO-$12.9M -17.6%
- STRYKER CORPORATION-$10.7M -59.6%
New Positions
- INDIVIOR PHARMACEUTICALS INC$17.5M
- ABBOTT LABORATORIES$14.4M
- ACADIA HEALTHCARE COMPANY IN$13.6M
- NATERA INC$12.0M
- SCHEIN HENRY INC$11.3M
Exited Positions
- ADMA BIOLOGICS INC$23.2M
- MEDTRONIC PLC$20.5M
- MERCK & CO INC$19.8M
- INDIVIOR PLC$12.9M
- UNIVERSAL HLTH SVCS INC$12.5M
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | TENET HEALTHCARE CORP | THC | 88033G407 | $75.2M | 6.86% | 398,567 | SH |
| 2 | ELI LILLY & CO | LLY | 532457108 | $60.5M | 5.52% | 65,762 | SH |
| 3 | SPDR SERIES TRUST Put | XBI | 78464A870 | $58.2M | 5.30% | 455,300 | SH |
| 4 | PENUMBRA INC | PEN | 70975L107 | $45.9M | 4.19% | 139,779 | SH |
| 5 | AXSOME THERAPEUTICS INC. | AXSM | 05464T104 | $44.7M | 4.07% | 264,304 | SH |
| 6 | SELECT SECTOR SPDR TR Call | XLV | 81369Y209 | $35.0M | 3.19% | 238,900 | SH |
| 7 | ASCENDIS PHARMA A/S | ASND | 04351P101 | $34.8M | 3.17% | 152,034 | SH |
| 8 | JAZZ PHARMACEUTICALS PLC | JAZZ | G50871105 | $33.7M | 3.07% | 178,144 | SH |
| 9 | NEUROCRINE BIOSCIENCES INC | NBIX | 64125C109 | $28.4M | 2.59% | 215,678 | SH |
| 10 | UNITED THERAPEUTICS CORP DEL Put | UTHR | 91307C102 | $27.2M | 2.48% | 45,900 | SH |
| 11 | UNITED THERAPEUTICS CORP DEL | UTHR | 91307C102 | $23.6M | 2.15% | 39,805 | SH |
| 12 | GLAUKOS CORP | GKOS | 377322102 | $23.2M | 2.12% | 215,685 | SH |
| 13 | CENTESSA PHARMACEUTICALS PLC | CNTA | 152309100 | $21.0M | 1.91% | 528,224 | SH |
| 14 | INHIBRX BIOSCIENCES INC | INBX | 45720N103 | $20.5M | 1.87% | 305,431 | SH |
| 15 | EDWARDS LIFESCIENCES CORP | EW | 28176E108 | $20.4M | 1.86% | 254,510 | SH |
| 16 | BRIDGEBIO PHARMA INC | BBIO | 10806X102 | $19.1M | 1.75% | 257,747 | SH |
| 17 | UNITED THERAPEUTICS CORP DEL Call | UTHR | 91307C102 | $18.8M | 1.71% | 31,700 | SH |
| 18 | MADRIGAL PHARMACEUTICALS INC | MDGL | 558868105 | $17.9M | 1.63% | 34,146 | SH |
| 19 | INDIVIOR PHARMACEUTICALS INC | INDV | 45579U109 | $17.5M | 1.60% | 574,666 | SH |
| 20 | ASCENDIS PHARMA A/S | ASND | 04351PAD3 | $16.9M | 1.54% | 11,505,000 | PRN |
| 21 | UNITEDHEALTH GROUP INC | UNH | 91324P102 | $15.7M | 1.43% | 58,038 | SH |
| 22 | DIANTHUS THERAPEUTICS INC | DNTH | 252828108 | $14.4M | 1.32% | 172,137 | SH |
| 23 | ABBOTT LABORATORIES | ABT | 002824100 | $14.4M | 1.31% | 140,432 | SH |
| 24 | REVOLUTION MEDICINES INC | RVMD | 76155X100 | $13.7M | 1.25% | 140,770 | SH |
| 25 | ACADIA HEALTHCARE COMPANY IN | ACHC | 00404A109 | $13.6M | 1.24% | 582,745 | SH |
| 26 | NEOGENOMICS INC | NEO | 64049M209 | $13.2M | 1.21% | 1,784,552 | SH |
| 27 | COOPER COS INC | COO | 216648501 | $12.1M | 1.11% | 169,829 | SH |
| 28 | NATERA INC | NTRA | 632307104 | $12.0M | 1.09% | 60,004 | SH |
| 29 | INTEGER HLDGS CORP | ITGR | 45826H109 | $11.9M | 1.08% | 135,081 | SH |
| 30 | RHYTHM PHARMACEUTICALS INC | RYTM | 76243J105 | $11.9M | 1.08% | 136,621 | SH |
| 31 | WATERS CORP | WAT | 941848103 | $11.8M | 1.08% | 39,763 | SH |
| 32 | AMNEAL PHARMACEUTICALS INC | AMRX | 03168L105 | $11.6M | 1.05% | 930,096 | SH |
| 33 | PRAXIS PRECISION MEDICINES I | PRAX | 74006W207 | $11.4M | 1.04% | 35,438 | SH |
| 34 | SCHEIN HENRY INC | HSIC | 806407102 | $11.3M | 1.03% | 153,114 | SH |
| 35 | CG ONCOLOGY INC | CGON | 156944100 | $11.2M | 1.02% | 165,925 | SH |
| 36 | MERIT MED SYS INC | MMSI | 589889104 | $11.2M | 1.02% | 162,469 | SH |
| 37 | CELLDEX THERAPEUTICS INC NEW | CLDX | 15117B202 | $10.3M | 0.94% | 324,957 | SH |
| 38 | BELITE BIO INC | BLTE | 07782B104 | $9.5M | 0.86% | 59,432 | SH |
| 39 | DEXCOM INC | DXCM | 252131107 | $9.4M | 0.86% | 149,734 | SH |
| 40 | TERNS PHARMACEUTICALS INC | TERN | 880881107 | $9.1M | 0.83% | 172,962 | SH |
| 41 | CENTENE CORP DEL | CNC | 15135B101 | $8.6M | 0.79% | 263,486 | SH |
| 42 | VIKING THERAPEUTICS INC | VKTX | 92686J106 | $8.6M | 0.78% | 263,106 | SH |
| 43 | ORUKA THERAPEUTICS INC | ORKA | 687604108 | $8.5M | 0.78% | 174,052 | SH |
| 44 | TANGO THERAPEUTICS INC | TNGX | 87583X109 | $8.5M | 0.77% | 406,245 | SH |
| 45 | SOLENO THERAPEUTICS INC | SLNO | 834203309 | $8.3M | 0.76% | 248,180 | SH |
| 46 | BRIGHTSPRING HEALTH SVCS INC | BTSG | 10950A106 | $8.0M | 0.73% | 187,335 | SH |
| 47 | COMPASS PATHWAYS PLC | CMPS | 20451W101 | $7.6M | 0.69% | 1,367,099 | SH |
| 48 | THERMO FISHER SCIENTIFIC INC | TMO | 883556102 | $7.3M | 0.66% | 14,832 | SH |
| 49 | NOVO-NORDISK A S | NVO | 670100205 | $7.2M | 0.66% | 197,181 | SH |
| 50 | STRYKER CORPORATION | SYK | 863667101 | $7.2M | 0.66% | 21,957 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-03-31 | 2026-05-15 | $1.10B | 83 | 0001442756-26-000002 |
| 2025-12-31 | 2026-02-17 | $1.00B | 78 | 0001442756-26-000001 |
| 2025-09-30 | 2025-11-14 | $1.30B | 72 | 0001442756-25-000007 |